These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11221468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M, Omawari N, Tomlinson DR.
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The protective effect of NG-nitro-L-arginine methyl ester and insulin on nitric oxide inhibition and pathology in experimental diabetic rat liver.
    Ozden H, Tekin N, Akyuz F, Gurer F, Ustuner MC, Kucuk F, Guven G, Yaylak F.
    Saudi Med J; 2009 Jan; 30(1):30-4. PubMed ID: 19139769
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of selective iNOS inhibition on systemic hemodynamics and mortality rate on endotoxic shock in streptozotocin-induced diabetic rats.
    Kadoi Y, Goto F.
    Shock; 2007 Nov; 28(5):602-9. PubMed ID: 17607161
    [Abstract] [Full Text] [Related]

  • 10. [The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME].
    Kapitola J, Andrle J, Haas T, Kubícková J.
    Sb Lek; 1996 Nov; 97(4):455-61. PubMed ID: 9424710
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D, Cederbaum A.
    Toxicol Appl Pharmacol; 2006 Oct 15; 216(2):282-92. PubMed ID: 16938321
    [Abstract] [Full Text] [Related]

  • 15. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H, Pechánová O, Kunes J, Vokurková M, Dobesová Z, Zicha J.
    Hypertens Res; 2005 May 15; 28(5):475-82. PubMed ID: 16156512
    [Abstract] [Full Text] [Related]

  • 16. Influence of NG-nitro-L-arginine methyl ester on clinical and biochemical effects of methylene blue in pentylenetetrazole-evoked convulsions.
    Jelenković A, Jovanović MD, Bokonjić D, Maksimović M, Bosković B.
    Vojnosanit Pregl; 2012 Jun 15; 69(6):481-7. PubMed ID: 22779292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.
    Invest Ophthalmol Vis Sci; 2007 Nov 15; 48(11):5257-65. PubMed ID: 17962481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.